本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Biohaven Pharmaceutical Holding Co Ltd.

15.71
+1.4810.40%
成交量:281.48萬
成交額:4,343.52萬
市值:16.62億
市盈率:-2.05
高:15.83
開:14.41
低:14.36
收:14.23
52周最高:55.70
52周最低:12.79
股本:1.06億
流通股本:8,775.36萬
量比:1.34
換手率:3.21%
股息:- -
股息率:- -
每股收益(TTM):-7.6523
每股收益(LYR):-9.2774
淨資產收益率:-295.94%
總資產收益率:-103.41%
市淨率:12.35
市盈率(LYR):-1.69

資料載入中...

2023/07/31

重要事件披露

Form 8-K - Current report
2023/07/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/29

重要事件披露

Form 8-K - Current report
2023/05/31

重要事件披露

Form 8-K - Current report
2023/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/12

重要事件披露

Form 8-K - Current report
2022/10/04

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2022/10/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

重要事件披露

8-K - Current report
2022/09/29

重要事件披露

8-K - Current report
2022/09/27

重要事件披露

8-K - Current report
2022/09/23

重要事件披露

8-K - Current report
2022/09/23

重要事件披露

8-K - Current report
2022/09/19

重要事件披露

8-K - Current report
2022/09/19

重要事件披露

8-K - Current report
2022/08/05

重要事件披露

8-K - Current report